As I think I said I have given her a constitutional remedy so will see how that goes but I was thinking ahead as this is a layered case. She is through menopause now but taking HRT!!!!!!
Rochelle
Registered Homeopath, EFT(Advanced)Practitioner
www.southporthomeopathy.co.uk
Progesterone
Re: Progesterone
Hello, everyone -
all this talk about progesterone made me remember homoeopathic (?)
HGH, i.e. Human Growth Hormone. Can anyone refer me to any actual
provings or other experiences you might have had with it? (All I've
been able to find so far - not that I tried VERY hard - wes info from
commercial sites.)
Kind regards,
A.
all this talk about progesterone made me remember homoeopathic (?)
HGH, i.e. Human Growth Hormone. Can anyone refer me to any actual
provings or other experiences you might have had with it? (All I've
been able to find so far - not that I tried VERY hard - wes info from
commercial sites.)
Kind regards,
A.
-
Shannon Nelson
- Posts: 8848
- Joined: Fri Jun 28, 2002 10:00 pm
Re: Progesterone
Hi Rochelle,
I read so many bad things about HRT... LOTS of bad things. Is she
doing it for some particular problem, or assuming it will reduce bone
loss, or ?? Shannon
[Non-text portions of this message have been removed]
I read so many bad things about HRT... LOTS of bad things. Is she
doing it for some particular problem, or assuming it will reduce bone
loss, or ?? Shannon
[Non-text portions of this message have been removed]
-
Sarvadaman Oberoi
- Posts: 156
- Joined: Sun Nov 06, 2005 11:00 pm
Re: Progesterone
This proving does not inspire confidence but thats all there is.
Regards.
Sarvadaman Oberoi
New Delhi, India
Mobile: +919818768349
+911244076374
Website: http://www.freewebs.com/homeopathy249/
Hello, everyone -
all this talk about progesterone made me remember homoeopathic (?)
HGH, i.e. Human Growth Hormone. Can anyone refer me to any actual
provings or other experiences you might have had with it? (All I've
been able to find so far - not that I tried VERY hard - wes info from
commercial sites.)
Kind regards,
A.
HGH:
hGH, Homeopathic Provings
http://www.biomedcomm.com/store/pi_hgh_proving.html
Proving Report Human Growth Hormone (hGH)
Also see:
Proving Report Insulin-like Growth Factor-1 (IGF1)
Peer Reviewed Scientific Publications
Proving Report
Proving Protocol
Clinical Trial Design
Clinical Investigators
Methodology
Medications
Subject Population
Subject Inclusion Criteria
Subject Exclusion Criteria
General Drug Proving Outline
Medication Administration
Symptom Collection and Evaluation
Proving Time-line
Materia Medica - Human Growth Hormone
Proving Report
Symptoms in the language of the prover are organized in the traditional
homeopathic format (as found in Boericke) and selected according to the
following criteria:
modalities (something which makes a symptom better or worse)
concomitants (something occurring in conjunction with a symptom)
timing of the symptom (periodicity, specificity of timing)
localization (sides, extension)
unique descriptions of a symptom (descriptive adjectives)
intensity of the symptom
a symptom is new or has not been experienced in the past 12 months
a symptom occurred after taking the medication on at least two occasions
during the homeopathic drug proving
a symptom experienced when the proving started which disappeared or is
significantly ameliorated after the administration of the proving
medication, is classified as a cured symptom
a symptom was experienced in more than one prover
Proving Protocol
Clinical Trial Design
Homeopathic drug provings are similar but not identical to Phase I clinical
trials outlined in the Code of Federal Regulation (CFR) and the European
Union (EU) guidelines for clinical research. These guidelines have been used
to design this trial.
Clinical Investigators
Proving Director - David Riley, MD
Proving Supervisors - Sally Lenetsky, RN
Proving Coordinator - Anna Bell Romero
Methodology
Data Collecting - Diary/journal format
Study Design - Double group (6X and 6C) with placebo run-in
Method of Binding - Double-Blind
Controls - Intra-individual controls, placebo run-in, placebo controls
Medications
The medication used in this homeopathic drug proving was prepared by Dolisos
in the United States according to HPCUS guidelines.
Subject Populations
There were 50 subjects in this homeopathic drug proving, 20 subjects
received HGH in a 6X potency, 20 subjects received HGH in a 6C potency, and
10 subjects received a placebo. 50 subjects: 39 women and 11 men ranging in
age from 23 to 56 years. 40 subjects received verum, 10 received placebo.
There were 4 dropouts from this homeopathic drug proving.
Subject Inclusion Criteria - each subject
was in a general state of good health for that person according to the
proving director, proving supervisor and the subject.
agreed in advance to comply with instructions for keeping a journal. The
subject observed and described symptoms experienced from taking a
homeopathic medication.
did not engage in any elective medical treatments (such as surgery or dental
procedures) for the duration of the homeopathic drug proving.
did not undergo any major life changes (moving, getting married or divorced,
etc.) and continued the usual habits and patterns of daily life.
was over the age of 18, competent, and signed the informed consent.
was given a Myers-Briggs Type Indicator
Subject Exclusion Criteria - each subject
was in ongoing medical treatment during the homeopathic drug proving
had surgery within the past 6 weeks
was on prescription medication
had taken birth control pills in the past 6 months
was pregnant or nursing
failed to complete the journal as instructed
General Drug Proving Outline
This homeopathic drug proving was conducted between December 1998 and
February 1999. Subjects were recruited by advertisement. Subjects were
included according to the above criteria and signed an informed consent upon
entry into the proving. They attended at least two training sessions about
homeopathy and a homeopathic drug proving prior to being accepted into the
homeopathic drug proving. Each subject was given a copy of a previously
conducted proving at the first training session. A routine medical
evaluation was performed on all accepted subjects.
This homeopathic drug proving lasted 7 weeks per subject. Phase I was a one
week pre-proving observation period which established the baseline rhythm of
each subject's daily life in a diary format. Phase II was a two week placebo
run-in phase. Phase III was a two week medication phase during which
subjects were randomized to one of three groups, 6X HGH, 6C HGH, or placebo.
Phase IV was a two week post-proving observation phase. This was a single
case-study with three types of control: an intra-individual control
comparing the pre-medication phase with medication phase, a placebo run-in
control as the first medication phase, and placebo controls during the
second medication phase.
Medication Adminstration
The homeopathic medications were administered two weeks apart in a similar
fashion. The first administration of the medication was a placebo. The
medication was administered 3 times daily until the subject developed
symptoms or for seven days. They continued keeping their journal throughout
this phase of the clinical trial. Each subject reported any potential
symptoms to the proving director or supervisors as soon as possible. After
two weeks the subjects were given a second medication administered in a
similar fashion for seven days. The second bottle was verum or placebo
according to a randomized code known only by the sponsor.
Symptom Collection and Evaluation
Subjects noted symptoms in their journals for the duration of the
homeopathic drug proving and were in regular contact with the proving
director or supervisor. The symptoms experienced after the administration of
the medication were compared with the baseline pre-proving observations and
evaluated according to the criteria mentioned at the beginning of this
report. Symptoms experienced during the randomization phase were excluded
for a subject if they were the same symptoms experienced during the placebo
run-in phase. All subjects completed an exit interview where each symptom
experienced was reviewed again for additional clarification. All symptoms
were reviewed by the proving supervisors and the proving director. Some
subjects experienced a relief from chronically experienced symptoms; these
have been included in the final report. There were no adverse effects noted
at the time of the exit interview or during the post-proving observation
period.
Proving Time-line
Week 1 2 3 4 5 6 7
Initial Interview x
Inclusion/Exclusion Criteria x
Initial Evaluation x
Subject Education x
Phase I: Pre-proving observation x
Phase II: Placebo run-in phase x
Phase II: Medication/Placebo x
Data collection in Journal x x x x x
Phase III: Exit Interview x
Phase III: Post-proving observation x x
Observation for adverse effects x x x x x x
Materia Medica - Human Growth Hormone
Materia medicus (encyclopedia of drug effects) represents the therapeutic
indications for the tested drug as a result of the proving.
The essential characteristics (in bold) are defined as those symptoms that
occurred the most frequently in the provers.
Precise detailed toxicological studies have been conducted for the majority
of the modern drugs in use today, i.e., in practice, their overdose effects
are known. These effect could be compared to a homeopathic "proving." Thus,
according to homeopathic reasoning, it should be possible to obtain
therapeutic results using diluted, dynamized preparations of these drugs in
two situations: a) patients with symptoms similar to those notoriously
caused by the drug on healthy subjects, b) patients presenting such symptoms
as adverse effects of the drug administered at high doses.
Essential Characterisitcs
Many vivid dreams were noted by a variety of provers. Mental concentration
was noted to be improved. In general there was a consistent observation in
seven of the subjects of a noticeable increase in their level of energy and
in related areas of mental concentration and strength. Appetites were
usually increased (11 subjects) or occasionally decreased. Nasal congestion.
Ulcerations of the mouth. Cramping pains in various parts of the body.
Mind
Vivid dreams. Improvement in concentration. Colorful , vivid dreams. Strange
dreams. Discontented, impatient and irritable. Headaches.
Generalities
Energy increased (cured symptom) as well as decrease in energy. Desires for
a variety of foods and flavors including salty, chocolate, sweets, and
soups.
Head Pain
Headaches: worse in the temples and behind the ears and also behind the
eyes. Pain quality was like a band. Headaches worse on the left side.
Eye
Irritation with watering
Nose
Congestion with sneezing. Congestion alternating with coryza.
Face
Tightness. Irritation. Dryness.
Mouth
Apthae.
Throat
Irritation with scratching and cough with phlegm.
Stomach
Increase in appetite in 11 subjects as well as a decrease in two subjects.
Increase in thirst.
Abdomen
Cramping in the lower abdomen, worse on the left side.
Rectum
Constipation without a feeling of urging. Pain in the rectum when urinating.
Stool
Sticky consistency.
Bladder
Pain in the rectum when urinating.
Genitalia, Female
Uterine cramping. One case of return of normal menses (cured symptom).
Chest
Cramping in the area of the ribcage.
Back
Cramping.
Extremities/Extremity Pain
Cramping with pain throughout the extremities, worse in the calves.
Eruptions on the thighs.
Sleep
Restless or deep sleep.
We reserve the right to refuse sale of Biomed Comm products to any one we
chose not to sell to.
Copyright(c) 2004 Biomed Comm,(r) Inc.
[Non-text portions of this message have been removed]
Regards.
Sarvadaman Oberoi
New Delhi, India
Mobile: +919818768349
+911244076374
Website: http://www.freewebs.com/homeopathy249/
Hello, everyone -
all this talk about progesterone made me remember homoeopathic (?)
HGH, i.e. Human Growth Hormone. Can anyone refer me to any actual
provings or other experiences you might have had with it? (All I've
been able to find so far - not that I tried VERY hard - wes info from
commercial sites.)
Kind regards,
A.
HGH:
hGH, Homeopathic Provings
http://www.biomedcomm.com/store/pi_hgh_proving.html
Proving Report Human Growth Hormone (hGH)
Also see:
Proving Report Insulin-like Growth Factor-1 (IGF1)
Peer Reviewed Scientific Publications
Proving Report
Proving Protocol
Clinical Trial Design
Clinical Investigators
Methodology
Medications
Subject Population
Subject Inclusion Criteria
Subject Exclusion Criteria
General Drug Proving Outline
Medication Administration
Symptom Collection and Evaluation
Proving Time-line
Materia Medica - Human Growth Hormone
Proving Report
Symptoms in the language of the prover are organized in the traditional
homeopathic format (as found in Boericke) and selected according to the
following criteria:
modalities (something which makes a symptom better or worse)
concomitants (something occurring in conjunction with a symptom)
timing of the symptom (periodicity, specificity of timing)
localization (sides, extension)
unique descriptions of a symptom (descriptive adjectives)
intensity of the symptom
a symptom is new or has not been experienced in the past 12 months
a symptom occurred after taking the medication on at least two occasions
during the homeopathic drug proving
a symptom experienced when the proving started which disappeared or is
significantly ameliorated after the administration of the proving
medication, is classified as a cured symptom
a symptom was experienced in more than one prover
Proving Protocol
Clinical Trial Design
Homeopathic drug provings are similar but not identical to Phase I clinical
trials outlined in the Code of Federal Regulation (CFR) and the European
Union (EU) guidelines for clinical research. These guidelines have been used
to design this trial.
Clinical Investigators
Proving Director - David Riley, MD
Proving Supervisors - Sally Lenetsky, RN
Proving Coordinator - Anna Bell Romero
Methodology
Data Collecting - Diary/journal format
Study Design - Double group (6X and 6C) with placebo run-in
Method of Binding - Double-Blind
Controls - Intra-individual controls, placebo run-in, placebo controls
Medications
The medication used in this homeopathic drug proving was prepared by Dolisos
in the United States according to HPCUS guidelines.
Subject Populations
There were 50 subjects in this homeopathic drug proving, 20 subjects
received HGH in a 6X potency, 20 subjects received HGH in a 6C potency, and
10 subjects received a placebo. 50 subjects: 39 women and 11 men ranging in
age from 23 to 56 years. 40 subjects received verum, 10 received placebo.
There were 4 dropouts from this homeopathic drug proving.
Subject Inclusion Criteria - each subject
was in a general state of good health for that person according to the
proving director, proving supervisor and the subject.
agreed in advance to comply with instructions for keeping a journal. The
subject observed and described symptoms experienced from taking a
homeopathic medication.
did not engage in any elective medical treatments (such as surgery or dental
procedures) for the duration of the homeopathic drug proving.
did not undergo any major life changes (moving, getting married or divorced,
etc.) and continued the usual habits and patterns of daily life.
was over the age of 18, competent, and signed the informed consent.
was given a Myers-Briggs Type Indicator
Subject Exclusion Criteria - each subject
was in ongoing medical treatment during the homeopathic drug proving
had surgery within the past 6 weeks
was on prescription medication
had taken birth control pills in the past 6 months
was pregnant or nursing
failed to complete the journal as instructed
General Drug Proving Outline
This homeopathic drug proving was conducted between December 1998 and
February 1999. Subjects were recruited by advertisement. Subjects were
included according to the above criteria and signed an informed consent upon
entry into the proving. They attended at least two training sessions about
homeopathy and a homeopathic drug proving prior to being accepted into the
homeopathic drug proving. Each subject was given a copy of a previously
conducted proving at the first training session. A routine medical
evaluation was performed on all accepted subjects.
This homeopathic drug proving lasted 7 weeks per subject. Phase I was a one
week pre-proving observation period which established the baseline rhythm of
each subject's daily life in a diary format. Phase II was a two week placebo
run-in phase. Phase III was a two week medication phase during which
subjects were randomized to one of three groups, 6X HGH, 6C HGH, or placebo.
Phase IV was a two week post-proving observation phase. This was a single
case-study with three types of control: an intra-individual control
comparing the pre-medication phase with medication phase, a placebo run-in
control as the first medication phase, and placebo controls during the
second medication phase.
Medication Adminstration
The homeopathic medications were administered two weeks apart in a similar
fashion. The first administration of the medication was a placebo. The
medication was administered 3 times daily until the subject developed
symptoms or for seven days. They continued keeping their journal throughout
this phase of the clinical trial. Each subject reported any potential
symptoms to the proving director or supervisors as soon as possible. After
two weeks the subjects were given a second medication administered in a
similar fashion for seven days. The second bottle was verum or placebo
according to a randomized code known only by the sponsor.
Symptom Collection and Evaluation
Subjects noted symptoms in their journals for the duration of the
homeopathic drug proving and were in regular contact with the proving
director or supervisor. The symptoms experienced after the administration of
the medication were compared with the baseline pre-proving observations and
evaluated according to the criteria mentioned at the beginning of this
report. Symptoms experienced during the randomization phase were excluded
for a subject if they were the same symptoms experienced during the placebo
run-in phase. All subjects completed an exit interview where each symptom
experienced was reviewed again for additional clarification. All symptoms
were reviewed by the proving supervisors and the proving director. Some
subjects experienced a relief from chronically experienced symptoms; these
have been included in the final report. There were no adverse effects noted
at the time of the exit interview or during the post-proving observation
period.
Proving Time-line
Week 1 2 3 4 5 6 7
Initial Interview x
Inclusion/Exclusion Criteria x
Initial Evaluation x
Subject Education x
Phase I: Pre-proving observation x
Phase II: Placebo run-in phase x
Phase II: Medication/Placebo x
Data collection in Journal x x x x x
Phase III: Exit Interview x
Phase III: Post-proving observation x x
Observation for adverse effects x x x x x x
Materia Medica - Human Growth Hormone
Materia medicus (encyclopedia of drug effects) represents the therapeutic
indications for the tested drug as a result of the proving.
The essential characteristics (in bold) are defined as those symptoms that
occurred the most frequently in the provers.
Precise detailed toxicological studies have been conducted for the majority
of the modern drugs in use today, i.e., in practice, their overdose effects
are known. These effect could be compared to a homeopathic "proving." Thus,
according to homeopathic reasoning, it should be possible to obtain
therapeutic results using diluted, dynamized preparations of these drugs in
two situations: a) patients with symptoms similar to those notoriously
caused by the drug on healthy subjects, b) patients presenting such symptoms
as adverse effects of the drug administered at high doses.
Essential Characterisitcs
Many vivid dreams were noted by a variety of provers. Mental concentration
was noted to be improved. In general there was a consistent observation in
seven of the subjects of a noticeable increase in their level of energy and
in related areas of mental concentration and strength. Appetites were
usually increased (11 subjects) or occasionally decreased. Nasal congestion.
Ulcerations of the mouth. Cramping pains in various parts of the body.
Mind
Vivid dreams. Improvement in concentration. Colorful , vivid dreams. Strange
dreams. Discontented, impatient and irritable. Headaches.
Generalities
Energy increased (cured symptom) as well as decrease in energy. Desires for
a variety of foods and flavors including salty, chocolate, sweets, and
soups.
Head Pain
Headaches: worse in the temples and behind the ears and also behind the
eyes. Pain quality was like a band. Headaches worse on the left side.
Eye
Irritation with watering
Nose
Congestion with sneezing. Congestion alternating with coryza.
Face
Tightness. Irritation. Dryness.
Mouth
Apthae.
Throat
Irritation with scratching and cough with phlegm.
Stomach
Increase in appetite in 11 subjects as well as a decrease in two subjects.
Increase in thirst.
Abdomen
Cramping in the lower abdomen, worse on the left side.
Rectum
Constipation without a feeling of urging. Pain in the rectum when urinating.
Stool
Sticky consistency.
Bladder
Pain in the rectum when urinating.
Genitalia, Female
Uterine cramping. One case of return of normal menses (cured symptom).
Chest
Cramping in the area of the ribcage.
Back
Cramping.
Extremities/Extremity Pain
Cramping with pain throughout the extremities, worse in the calves.
Eruptions on the thighs.
Sleep
Restless or deep sleep.
We reserve the right to refuse sale of Biomed Comm products to any one we
chose not to sell to.
Copyright(c) 2004 Biomed Comm,(r) Inc.
[Non-text portions of this message have been removed]
Re: Progesterone
--- In minutus@yahoogroups.com, "Sarvadaman Oberoi"
wrote:
My thoughts exactly.
Thank you very much.
A.
wrote:
My thoughts exactly.
Thank you very much.
A.
-
Jean Doherty
- Posts: 1576
- Joined: Fri Apr 12, 2002 10:00 pm
Re: Progesterone
. I believe gyms may be the best source of information , Best Wishes
Jean
[Non-text portions of this message have been removed]
Jean
[Non-text portions of this message have been removed]
-
Rochelle Marsden
- Posts: 2005
- Joined: Tue Nov 19, 2013 11:00 pm
Re: Progesterone
Apparently because of the bad PMT stuff she went from the pill to HRT. She is happy taking the HRT so once homeopathy starts to sort her other stuff out I will have a go for her to stop that slowly!! It is a complex case.
Registered Homeopath, EFT(Advanced)Practitioner
www.southporthomeopathy.co.uk
Registered Homeopath, EFT(Advanced)Practitioner
www.southporthomeopathy.co.uk
Re: Progesterone
Thanks.
The whole thing - "homoeopathic" HGH (as a body/mind "enhancer", that
is)- never made much sense to me...
But maybe it's just me.
A.
--- In minutus@yahoogroups.com, Jean Doherty wrote:
The whole thing - "homoeopathic" HGH (as a body/mind "enhancer", that
is)- never made much sense to me...
But maybe it's just me.
A.
--- In minutus@yahoogroups.com, Jean Doherty wrote:
-
Shannon Nelson
- Posts: 8848
- Joined: Fri Jun 28, 2002 10:00 pm
Re: Progesterone
Hi Rochelle,
If you feel up to talking a bit about the complexity of it, that might
be a useful discussion! I've always figured that (and wondered
whether) when a case looks "complex", it isn't simply that I haven't
been able to see the pattern within the "story"--or haven't matched
that with an appropriate remedy. Now I *don't* mean to say that I
"don't believe in" organ remedies or "layers"...
I don't want to put you on the spot, Rochelle--but do you want to try
some discussion about the "complex" issue with reference to your
case--what makes it look complex to you, and what have your thoughts
been about how to approach that--and see what others' thoughts about it
might be?
Shannon
[Non-text portions of this message have been removed]
If you feel up to talking a bit about the complexity of it, that might
be a useful discussion! I've always figured that (and wondered
whether) when a case looks "complex", it isn't simply that I haven't
been able to see the pattern within the "story"--or haven't matched
that with an appropriate remedy. Now I *don't* mean to say that I
"don't believe in" organ remedies or "layers"...
I don't want to put you on the spot, Rochelle--but do you want to try
some discussion about the "complex" issue with reference to your
case--what makes it look complex to you, and what have your thoughts
been about how to approach that--and see what others' thoughts about it
might be?
Shannon
[Non-text portions of this message have been removed]
-
Shannon Nelson
- Posts: 8848
- Joined: Fri Jun 28, 2002 10:00 pm
Re: Progesterone
It's certainly an allopathic approach to the "remedy", and I would
think could have only (at best) a palliative effect, not curative--and
in my experience, palliatives work for a while, then they stop working.
But I would be interested to hear others' experiences!
Shannon
[Non-text portions of this message have been removed]
think could have only (at best) a palliative effect, not curative--and
in my experience, palliatives work for a while, then they stop working.
But I would be interested to hear others' experiences!
Shannon
[Non-text portions of this message have been removed]